Home » Topics » Science » New compound

New compound
RSS

Daiwa's MGN-3 demonstrates immunotherapeutic activity

May 31, 1996

RPR-112378: A new inhibitor of tubulin polymerization

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Anthracycline antitumor agent FCE-23762 metabolites synthesized

May 31, 1996

M-246315: A new thymidylate synthase inhibitor

May 31, 1996

LL-95509 exhibits optimum activity against GARFT

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Shanghai Institute of Materia Medica reveals epibatidine analogue

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...